Can an app keep young HIV patients wearing alcohol trackers?

NCT ID NCT05431855

Completed Knowledge-focused Sponsor: Florida State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a smartphone app called eWrapper could help young adults with HIV wear an alcohol biosensor for 30 days. Sixty-six participants in Florida used the app, which offered rewards and personalized feedback to encourage sensor use. The goal was to see if these strategies improved how often people wore the sensor, not to change drinking behavior directly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: eWrapper app with engagement strategies (reciprocity and personalized feedback)
What this could lead to: If successful, this could point toward better ways to help young adults with HIV manage alcohol use through wearable technology.
What could go wrong: This is a small, completed feasibility study with only 66 participants. It tested engagement with a biosensor, not health outcomes, so results may not lead to direct clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

Florida State University

Tallahassee, Florida, 32310, United States
The University of Florida

Gainesville, Florida, 32611, United States
The University of Michigan

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.